What was big for pharma in 2018?

European Pharmaceutical Manufacturer speaks to some of the leading names in pharmaceutical manufacturing to find out what the key moments have been for them in 2018.

× Review

Jonathan Gaik, director, Natoli Scientific, Natoli Engineering

One of the biggest pharma breakthroughs this year happened when the FDA approved its first product derived from marijuana. The product is an oral solution containing cannabidiol (CBD) but the FDA was careful to stress that this approval did not translate into approval of marijuana or its other components. Many small companies make products that contain CBD, and

... read more at: https://www.epmmagazine.com/opinion/pharma-year-in-review/

by